Multiple relapses of Clostridium difficile-associated diarrhea in a cancer patient. Successful control with long-term cholestyramine therapy.
Clostridium difficile-associated diarrhea (CDAD) is caused by a toxin elaborated by the anaerobic organism Clostridium difficile. Although the vast majority of CDAD cases are now associated with antibiotic use, the administration of antineoplastic agents alone can result in clinical manifestations. While therapy with oral vancomycin is usually successful, one quarter of patients will relapse. We describe a 16-year-old girl with osteogenic sarcoma whose therapy was significantly complicated by multiple relapses of CDAD. All resulted in hospital admission. She failed several standard therapies for relapsed CDAD and was cured only after prolonged cholestyramine therapy. A subset of multiply relapsed CDAD patients may require prolonged therapy with cholestyramine to control the disease.
Moncino
M D
MD
Department of Pediatrics, University of Louisville, Kentucky.
Falletta
J M
JM
D000293:Adolescent; D000380:Agranulocytosis / Q000150:complications; D001859:Bone Neoplasms / Q000150:complications*; D002792:Cholestyramine Resin / Q000008:administration & dosage*; D003967:Diarrhea / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D004761:Enterocolitis, Pseudomembranous / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D012516:Osteosarcoma / Q000150:complications*; D012008:Recurrence; D013997:Time Factors
D002792:Cholestyramine Resin